Does OLANZAPINE Cause Product packaging quantity issue? 16 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Product packaging quantity issue have been filed in association with OLANZAPINE (Olanzapine). This represents 0.0% of all adverse event reports for OLANZAPINE.
16
Reports of Product packaging quantity issue with OLANZAPINE
0.0%
of all OLANZAPINE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product packaging quantity issue From OLANZAPINE?
Of the 16 reports.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLANZAPINE. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does OLANZAPINE Cause?
Drug ineffective (5,139)
Weight increased (3,588)
Off label use (3,256)
Toxicity to various agents (3,175)
Somnolence (2,612)
Sedation (2,130)
Suicide attempt (2,116)
Confusional state (1,898)
Condition aggravated (1,810)
Overdose (1,765)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which OLANZAPINE Alternatives Have Lower Product packaging quantity issue Risk?
OLANZAPINE vs OLANZAPINE\SAMIDORPHAN L-MALATE
OLANZAPINE vs OLAPARIB
OLANZAPINE vs OLARATUMAB
OLANZAPINE vs OLECLUMAB
OLANZAPINE vs OLIVE OIL\SOYBEAN OIL